Why Not Kids?

In collaboration with Amazon, ACCO is proud to announce Why Not Kids – an innovative state level approach to overcoming the disparity between adult and childhood cancer research. Using Kentucky as a successful model, Amazon + ACCO will strategically implement Why Not Kids across the country to advocate for policies and funding in recognition that children are not simply small adults. Childhood cancer is the #1 disease-related cause of death for children in the United States. However, in the last 2 decades more than 185 new drugs have been approved for treating adult cancers compared to 3 specifically for childhood cancer.

Why is this so important?

Childhood cancer is the number one cause of death by disease for children. Childhood cancer kills more children than all other diseases combined yet in the last 2 decades over 185 new drugs have been developed for treating adult cancers compared to only 3 specifically approved for kids.

While survival rates have improved, two-thirds of children who survive childhood cancer will face significant to life-threatening late effects. Many childhood cancer survivors experience heart issues, organ failure, infertility, and even secondary cancers. Our kids deserve targeted, genomics-based research and treatment so that they are not merely surviving but thriving.

Some cure rates remain at 0% Many children diagnosed with a pediatric brain tumor have no hope for survival and cure rates have remained the same for 40 years. Pediatric brain tumors have surpassed leukemia as the deadliest form of childhood cancer. Through research funding provided by Why Not Kids, epidemiologists at the University of Kentucky have identified three clusters of pediatric brain tumors within the state. In these areas there is an 87% statistically significant higher rate of children diagnosed with Central Nervous System/Brain Tumors than what would be expected in other areas.